Fluoride treatment for osteoporosis.
Nagant de Deuxchaisnes
C
C
Devogelaer
J P
JP
Stein
F
F
D001682:Biological Availability; D015519:Bone Density / Q000187:drug effects; D001862:Bone Resorption / Q000517:prevention & control; D004334:Drug Administration Schedule; D006801:Humans; D010024:Osteoporosis / Q000517:prevention & control*; D012969:Sodium Fluoride / Q000493:pharmacokinetics*; D013608:Tablets, Enteric-Coated
D013608:Tablets, Enteric-Coated; D012969:Sodium Fluoride